Cargando…

Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome

BACKGROUND: With the advance of antibiotics and life support therapy, the mortality of sepsis has been decreasing in recent years. However, the incidence of sepsis-associated encephalopathy (SAE), a common complication of sepsis, is still high. There are few effective therapies to treat clinical SAE...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Xiaoli, Xie, Lingli, Yang, Xiaolong, Liang, Fang, Yang, Yanliang, Tong, Jianbin, Zhong, Yanjun, Zhao, Kai, Tang, Yiting, Yuan, Chuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285451/
https://www.ncbi.nlm.nih.gov/pubmed/32517686
http://dx.doi.org/10.1186/s10020-020-00181-3
_version_ 1783544700664283136
author Zhong, Xiaoli
Xie, Lingli
Yang, Xiaolong
Liang, Fang
Yang, Yanliang
Tong, Jianbin
Zhong, Yanjun
Zhao, Kai
Tang, Yiting
Yuan, Chuang
author_facet Zhong, Xiaoli
Xie, Lingli
Yang, Xiaolong
Liang, Fang
Yang, Yanliang
Tong, Jianbin
Zhong, Yanjun
Zhao, Kai
Tang, Yiting
Yuan, Chuang
author_sort Zhong, Xiaoli
collection PubMed
description BACKGROUND: With the advance of antibiotics and life support therapy, the mortality of sepsis has been decreasing in recent years. However, the incidence of sepsis-associated encephalopathy (SAE), a common complication of sepsis, is still high. There are few effective therapies to treat clinical SAE. We previously found that ethyl pyruvate (EP), a metabolite derivative, is able to effectively inhibit the NLRP3 inflammasome activation. Administration of ethyl pyruvate protects mice against polymicrobial sepsis in cecal ligation and puncture (CLP) model. The aim of present study is to investigate if ethyl pyruvate is able to attenuate SAE. METHODS: After CLP, C57BL/6 mice were intraperitoneally or intrathecally injected with saline or ethyl pyruvate using the sham-operated mice as control. New Object Recognition (NOR) and Morris Water Maze (MWM) were conducted to determine the cognitive function. Brain pathology was assessed via immunohistochemistry. To investigate the mechanisms by which ethyl pyruvate prevent SAE, the activation of NLRP3 in the hippocampus and the microglia were determined using western blotting, and cognitive function, microglia activation, and neurogenesis were assessed using WT, Nlrp3(−/−) and Asc(−/−) mice in the sublethal CLP model. In addition, Nlrp3(−/−) and Asc(−/−) mice treated with saline or ethyl pyruvate were subjected to CLP. RESULTS: Ethyl pyruvate treatment significantly attenuated CLP-induced cognitive decline, microglia activation, and impaired neurogenesis. In addition, EP significantly decreased the NLRP3 level in the hippocampus of the CLP mice, and inhibited the cleavage of IL-1β induced by NLRP3 inflammsome in microglia. NLRP3 and ASC deficiency demonstrated similar protective effects against SAE. Nlrp3(−/−) and Asc(−/−) mice significantly improved cognitive function and brain pathology when compared with WT mice in the CLP models. Moreover, ethyl pyruvate did not have additional effects against SAE in Nlrp3(−/−) and Asc(−/−) mice. CONCLUSION: The results demonstrated that ethyl pyruvate confers protection against SAE through inhibiting the NLRP3 inflammasome.
format Online
Article
Text
id pubmed-7285451
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72854512020-06-14 Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome Zhong, Xiaoli Xie, Lingli Yang, Xiaolong Liang, Fang Yang, Yanliang Tong, Jianbin Zhong, Yanjun Zhao, Kai Tang, Yiting Yuan, Chuang Mol Med Research Article BACKGROUND: With the advance of antibiotics and life support therapy, the mortality of sepsis has been decreasing in recent years. However, the incidence of sepsis-associated encephalopathy (SAE), a common complication of sepsis, is still high. There are few effective therapies to treat clinical SAE. We previously found that ethyl pyruvate (EP), a metabolite derivative, is able to effectively inhibit the NLRP3 inflammasome activation. Administration of ethyl pyruvate protects mice against polymicrobial sepsis in cecal ligation and puncture (CLP) model. The aim of present study is to investigate if ethyl pyruvate is able to attenuate SAE. METHODS: After CLP, C57BL/6 mice were intraperitoneally or intrathecally injected with saline or ethyl pyruvate using the sham-operated mice as control. New Object Recognition (NOR) and Morris Water Maze (MWM) were conducted to determine the cognitive function. Brain pathology was assessed via immunohistochemistry. To investigate the mechanisms by which ethyl pyruvate prevent SAE, the activation of NLRP3 in the hippocampus and the microglia were determined using western blotting, and cognitive function, microglia activation, and neurogenesis were assessed using WT, Nlrp3(−/−) and Asc(−/−) mice in the sublethal CLP model. In addition, Nlrp3(−/−) and Asc(−/−) mice treated with saline or ethyl pyruvate were subjected to CLP. RESULTS: Ethyl pyruvate treatment significantly attenuated CLP-induced cognitive decline, microglia activation, and impaired neurogenesis. In addition, EP significantly decreased the NLRP3 level in the hippocampus of the CLP mice, and inhibited the cleavage of IL-1β induced by NLRP3 inflammsome in microglia. NLRP3 and ASC deficiency demonstrated similar protective effects against SAE. Nlrp3(−/−) and Asc(−/−) mice significantly improved cognitive function and brain pathology when compared with WT mice in the CLP models. Moreover, ethyl pyruvate did not have additional effects against SAE in Nlrp3(−/−) and Asc(−/−) mice. CONCLUSION: The results demonstrated that ethyl pyruvate confers protection against SAE through inhibiting the NLRP3 inflammasome. BioMed Central 2020-06-09 /pmc/articles/PMC7285451/ /pubmed/32517686 http://dx.doi.org/10.1186/s10020-020-00181-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Zhong, Xiaoli
Xie, Lingli
Yang, Xiaolong
Liang, Fang
Yang, Yanliang
Tong, Jianbin
Zhong, Yanjun
Zhao, Kai
Tang, Yiting
Yuan, Chuang
Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome
title Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome
title_full Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome
title_fullStr Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome
title_full_unstemmed Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome
title_short Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome
title_sort ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the nlrp3 inflammasome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285451/
https://www.ncbi.nlm.nih.gov/pubmed/32517686
http://dx.doi.org/10.1186/s10020-020-00181-3
work_keys_str_mv AT zhongxiaoli ethylpyruvateprotectsagainstsepsisassociatedencephalopathythroughinhibitingthenlrp3inflammasome
AT xielingli ethylpyruvateprotectsagainstsepsisassociatedencephalopathythroughinhibitingthenlrp3inflammasome
AT yangxiaolong ethylpyruvateprotectsagainstsepsisassociatedencephalopathythroughinhibitingthenlrp3inflammasome
AT liangfang ethylpyruvateprotectsagainstsepsisassociatedencephalopathythroughinhibitingthenlrp3inflammasome
AT yangyanliang ethylpyruvateprotectsagainstsepsisassociatedencephalopathythroughinhibitingthenlrp3inflammasome
AT tongjianbin ethylpyruvateprotectsagainstsepsisassociatedencephalopathythroughinhibitingthenlrp3inflammasome
AT zhongyanjun ethylpyruvateprotectsagainstsepsisassociatedencephalopathythroughinhibitingthenlrp3inflammasome
AT zhaokai ethylpyruvateprotectsagainstsepsisassociatedencephalopathythroughinhibitingthenlrp3inflammasome
AT tangyiting ethylpyruvateprotectsagainstsepsisassociatedencephalopathythroughinhibitingthenlrp3inflammasome
AT yuanchuang ethylpyruvateprotectsagainstsepsisassociatedencephalopathythroughinhibitingthenlrp3inflammasome